Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01537588
Other study ID # April 2009
Secondary ID
Status Completed
Phase N/A
First received February 14, 2012
Last updated March 9, 2015
Start date July 2009
Est. completion date July 2012

Study information

Verified date March 2015
Source Panam Clinic
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The aim of this study is to gain new knowledge on the impact of hamstring tendon harvest and apply that knowledge to the treatment and management of patients who undergo anterior cruciate ligament (ACL) reconstruction. There are three main components of this study:

1. How do muscle shape, size, strength, and ability to function change following hamstring grafting for ACL reconstruction;

2. How does physical activity change following ACL reconstruction;

3. Is there a difference in outcome if graft harvest is done from the injured versus uninjured limbs


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 2012
Est. primary completion date July 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- between 18 and 50 years old; isolated ACL rupture confirmed on MRI

Exclusion Criteria:

- other physical or mental health issues that affect ability to complete rehabilitation and/or study follow-ups

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Isolated Anterior Cruciate Ligament Rupture

Intervention

Other:
Autograft STG harvest from ACL-deficient leg
Semitendinosus-gracilis graft harvest is undertaken on same limb that is undergoing ACL reconstruction
Autograft harvest contralateral to ACL-deficient leg
Semitendinosus-gracilis graft harvest is undertaken on limb contralateral to that undergoing ACL reconstruction

Locations

Country Name City State
Canada Pan Am Clinic Winnipeg Manitoba

Sponsors (1)

Lead Sponsor Collaborator
Panam Clinic

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle cross sectional area Measured on bilateral MRI taken from ischial tuberosity to 10 cm below knee joint line 12 months post-surgery No
Secondary Knee flexion and extension isokinetic strength Eccentric anc concentric strength measured at 60, 150, and 270 degrees/second on dynamometer in sitting and in 5 degrees hip flexion 12-months post-surgery No
Secondary Physical activity 7-day record of activity using accelerometer. 12 months post-surgery No